Why the study?
Does low-dose aspirin prevent cardiovascular events in older patients for primary prevention?
Does low-dose aspirin prevent cardiovascular events in older patients for primary prevention?
Discusses the uncertainty of prophylactic low-dose aspirin for primary prevention of cardiovascular disease in older patients.
Low-dose aspirin is recommended widely for primary prevention of cardiovascular disease; for example, the U.S. Preventive Services Task Force believes that aspirin’s benefits probably outweigh its harms when the 5-year risk for coronary events exceeds 3%. But how would this recommendation play out in older …
No takes yet. Share an insight, caveat, or question.
Keith I. Marton (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: